Browse drugs

…lone and plasma exchange in intensive care and was commenced on natalizumab but deteriorated with a further reduction in level of conscious…

…h all patient biopsies, achieving the primary endpoint. Ex-vivo pembrolizumab response rate was 14% (2 of 14 samples evaluated thus far), whi…

…addition of two immunosuppressive therapies, anchored on either belimumab or voclosporin.3 4 Glucocorticoids should be administered initi…

…ed cyclophosphamide had more infections than those who received mycophenolate. Methotrexate was associated with lower infection rates than my…

…bouring the BRAF mutation. Complete remission was achieved with Rituximab, Cyclophosphamide, Hydroxydaunorubicin, Oncovin and Prednisone,…

…d peripheral nervous system and started on cyclophosphamide and prednisolone, with notable improvement. We outline challenges faced in this …

…ocol (paclitaxel, carboplatin, epirubicin, cyclophosphamide and pembrolizumab). Following the sixth cycle, she developed refractory focal sei…

…t otherwise specified (PTCL-NOS). The disease was refractory to brentuximab vedotin plus cyclophosphamide, doxorubicin and prednisone, SMILE and pr…

… immunotherapy, consistent with refractory SIADH. Initiation of tolvaptan, a selective vasopressin V2-receptor antagonist, successfully r…

…apeutic modalities include medical (antihypertensive, steroids, cyclophosphamide, etc) as well as surgical interventions.…

…onths. Most common medication exposure (ever) were MMF (58.5%), prednisone (44.5%), HCQ (34.7%), MTX (29.5%), IVIg (13.6%), and cyclophosp…

…onthly CYC pulses (750 mg/m 2) followed by at least one year of mycophenolate mofetil. Criteria for rescue HSCT or DMARD use post-HSCT were predefine…